Munoz, M. 2026. Aprepitant, When Used with Chemotherapy, Reduces the Risk of Recurrence, Metastasis, And Mortality in Patients with Breast Cancer: Aprepitant in Breast Cancer Outcomes. Pakistan Journal of Health Sciences. 7, 8 (Aug. 2026), 01–02. DOI:https://doi.org/10.54393/pjhs.v7i8.4537.